Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2022
Historique:
received: 01 04 2022
accepted: 23 06 2022
entrez: 8 7 2022
pubmed: 9 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

Pulmonary fibrosis and emphysema result in relatively maintained ventilation and reduced diffusing capacity. This pulmonary functional impairment complicates the evaluation of pulmonary function in patients with combined pulmonary fibrosis and emphysema (CPFE). Therefore, a single and easy-to-use pulmonary function index to evaluate patients with CPFE warrants further studies. Respiratory impedance can easily be provided by oscillometry and might be a candidate index to evaluate pulmonary function in patients with CPFE. As a preliminary study to assess the utility of respiratory impedance, we investigated the associations of physiological indices, including respiratory impedance, in patients with idiopathic pulmonary fibrosis (IPF) with and without emphysema. This retrospective study evaluated patients with IPF who did and did not satisfy the diagnostic criteria of CPFE. All patients underwent oscillometry, spirometry, and diffusing capacity for carbon monoxide (D In total, 47 patients were included (18 and 29 patients with CPFE and IPF, respectively). Respiratory reactance (Xrs) at 5 Hz (X5) in the inspiratory phase was associated with forced vital capacity (FVC) % predicted in patients with CPFE (r Emphysema might associate Xrs with ventilation and diffusing capacity in patients with IPF and emphysema. Given the multiple correlations of Xrs with FVC and D

Identifiants

pubmed: 35801120
doi: 10.2147/COPD.S368162
pii: 368162
pmc: PMC9255903
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1495-1506

Informations de copyright

© 2022 Yamamoto et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Eur Respir J. 2020 Feb 27;55(2):
pubmed: 31772002
J Appl Physiol (1985). 1991 Oct;71(4):1477-88
pubmed: 1757373
Am J Respir Cell Mol Biol. 2011 Jul;45(1):1-15
pubmed: 21057104
Am Rev Respir Dis. 1961 Dec;84:789-806
pubmed: 13875021
Eur Respir J. 2003 Dec;22(6):1026-41
pubmed: 14680096
Can Respir J. 2014 May-Jun;21(3):e55-60
pubmed: 24712014
BMC Pulm Med. 2015 Sep 03;15:100
pubmed: 26334728
Chest. 2019 Dec;156(6):1111-1119
pubmed: 31352035
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
Eur Respir J. 2004 Feb;23(2):232-40
pubmed: 14979497
Respir Med. 2007 May;101(5):989-94
pubmed: 17055236
Chest. 2013 Jul;144(1):234-240
pubmed: 23370641
Medicina (Kaunas). 2019 Sep 10;55(9):
pubmed: 31509942
Am J Respir Crit Care Med. 2010 Feb 1;181(3):218-25
pubmed: 19875683
Respir Physiol Neurobiol. 2016 Jan;220:62-8
pubmed: 26369446
Respirology. 2015 Jan;20(1):33-45
pubmed: 25219816
Int J Chron Obstruct Pulmon Dis. 2014 Feb 15;9:187-201
pubmed: 24600216
Chest. 2012 Jan;141(1):222-231
pubmed: 22215830
Eur Respir J. 2005 Oct;26(4):586-93
pubmed: 16204587
Eur Respir J. 2015 Oct;46(4):1113-30
pubmed: 26424523
Eur Respir Rev. 2018 Jan 24;27(147):
pubmed: 29367408
Am Rev Respir Dis. 1991 Feb;143(2):219-25
pubmed: 1990931
Eur J Med Res. 2010 Nov 4;15 Suppl 2:229-34
pubmed: 21147657
Eur Respir J. 2017 Jul 5;50(1):
pubmed: 28679612
Eur Respir J. 2007 Feb;29(2):363-74
pubmed: 17079262
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
ERJ Open Res. 2020 Dec 14;6(4):
pubmed: 33344627
Am Rev Respir Dis. 1973 May;107(5):744-52
pubmed: 4695626
Eur Respir J. 2020 Sep 10;56(3):
pubmed: 32444404
Intern Med. 2016;55(6):559-66
pubmed: 26984069
Chest. 1995 Jul;108(1):109-15
pubmed: 7606943
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Am J Respir Crit Care Med. 2011 Dec 15;184(12):1382-9
pubmed: 21940789
Respir Investig. 2014 Jul;52(4):242-50
pubmed: 24998371
Eur Respir J. 2011 Jul;38(1):176-83
pubmed: 21148225
Eur Respir Rev. 2014 Sep;23(133):350-5
pubmed: 25176971
Respir Physiol Neurobiol. 2020 Apr;275:103386
pubmed: 31931177
Am J Respir Crit Care Med. 1997 Apr;155(4):1367-75
pubmed: 9105081

Auteurs

Yuji Yamamoto (Y)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Haruhiko Hirata (H)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Takayuki Shiroyama (T)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Tomoki Kuge (T)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Kinnosuke Matsumoto (K)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Midori Yoneda (M)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Makoto Yamamoto (M)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Yujiro Naito (Y)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Yasuhiko Suga (Y)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Kiyoharu Fukushima (K)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Kotaro Miyake (K)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Shohei Koyama (S)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Kota Iwahori (K)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Izumi Nagatomo (I)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Yoshito Takeda (Y)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Atsushi Kumanogoh (A)

Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka, Japan.
Center for Infectious Diseases for Education and Research (CiDER), Osaka University, Suita, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH